{"id":50498,"date":"2026-02-03T06:32:10","date_gmt":"2026-02-03T05:32:10","guid":{"rendered":"https:\/\/theark.ch\/?p=50498"},"modified":"2026-02-03T06:32:11","modified_gmt":"2026-02-03T05:32:11","slug":"valsynthese-fine-chemicals-specialist-since-1983","status":"publish","type":"post","link":"https:\/\/theark.ch\/en\/news\/valsynthese-fine-chemicals-specialist-since-1983\/","title":{"rendered":"valsynth\u00e8se, fine chemicals specialist since 1983"},"content":{"rendered":"\n<h5 class=\"wp-block-heading\"><strong>founded in 1983 in gamsen, valsynth\u00e8se is a valais-based company specializing in fine chemicals and high-risk processes.<\/strong> <strong>a subsidiary of <a href=\"https:\/\/www.sse-schweiz.com\/en-us\" target=\"_blank\" rel=\"noreferrer noopener\">soci\u00e9t\u00e9 suisse des explosifs<\/a> (sse), it is a recognized player in custom synthesis for the pharmaceutical, agricultural and technology industries.<\/strong><\/h5>\n\n\n\n<p>the history of <a href=\"https:\/\/www.valsynthese.ch\/\" target=\"_blank\" rel=\"noreferrer noopener\">valsynth\u00e8se<\/a> is closely linked to that of nitroglycerine. initially used to dynamite the simplon tunnel, this substance has found a second life in cardiovascular treatments. this transition from explosive to drug illustrates the company&#8217;s ability to adapt its know-how to the demands of fine chemistry. today, valsynth\u00e8se produces around 1,000 tonnes of chemical substances a year, thanks to its 27 reactors, for some fifty customers around the world.<\/p>\n\n\n\n<p>among its notable achievements is betaine citrate, a treatment for digestive disorders. since 1983, four billion doses have been manufactured in gamsen, in collaboration with the french laboratory upsa. this emblematic product testifies to valsynth\u00e8se&#8217;s ability to develop sustainable, effective solutions.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\"><strong>major investments<\/strong><\/h5>\n\n\n\n<p>the company has also entered into a partnership with <a href=\"https:\/\/www.dsm-firmenich.com\/en\/home.html\" target=\"_blank\" rel=\"noreferrer noopener\">dsm-firmenich<\/a> for the production of bovaer, an additive designed to reduce methane emissions from livestock. this project has prevented the emission of 66,000 tonnes of co\u2082 since its launch.<\/p>\n\n\n\n<p>since 2019, the haute-vall\u00e9e-based company has invested over 15 million francs, mainly in human resources and equipment. valsynth\u00e8se relies on a family business culture and high working flexibility to attract and retain its talent. this approach encourages employee involvement in projects and strengthens their commitment.<\/p>\n\n\n\n<p>since its creation, valsynth\u00e8se has transformed its expertise in explosives chemistry into recognized know-how in fine chemicals. thanks to rigorous risk management and a strong customer focus, the valais-based company continues to grow, while remaining true to its roots.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\"><strong>valsynth\u00e8se in bref<\/strong><\/h5>\n\n\n\n<p><strong>founded<\/strong>\u2009: 1983<br><strong>head office\u2009<\/strong>: gamsen (brigue-glis)<br><strong>main areas of activity<\/strong>: custom chemical synthesis, manufacture of active pharmaceutical ingredients, high-risk chemistry<br><strong>number of employees<\/strong>\u2009: 75<br><strong>phone number <\/strong>\u2009: +41 27 922 71 11<br><strong>e-mail<\/strong>\u2009: <a href=\"mailto:info@valsynthese.ch\">info@valsynthese.ch<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>founded in 1983 in gamsen, valsynth\u00e8se is a valais-based company specializing in fine chemicals and high-risk processes. a subsidiary of soci\u00e9t\u00e9 suisse des explosifs (sse), it is a recognized player in custom synthesis for the pharmaceutical, agricultural and technology industries.<\/p>\n","protected":false},"author":3,"featured_media":50489,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[212],"tags":[],"class_list":["post-50498","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry"],"acf":[],"_links":{"self":[{"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/posts\/50498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/comments?post=50498"}],"version-history":[{"count":4,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/posts\/50498\/revisions"}],"predecessor-version":[{"id":50502,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/posts\/50498\/revisions\/50502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/media\/50489"}],"wp:attachment":[{"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/media?parent=50498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/categories?post=50498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theark.ch\/en\/wp-json\/wp\/v2\/tags?post=50498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}